These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16553235)

  • 1. [Health economics aspects of diabetes mellitus].
    Ostendorf GM
    Versicherungsmedizin; 2006 Mar; 58(1):45-6. PubMed ID: 16553235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Economic significance of diabetes in Germany].
    Ammon HP
    Med Monatsschr Pharm; 1999 Mar; 22(3):65-6. PubMed ID: 10097579
    [No Abstract]   [Full Text] [Related]  

  • 3. [By the year 2030 some 40% of the German population could be Type 2 diabetics--the big bang in the public health system].
    Fuessl HS
    MMW Fortschr Med; 2006 May; 148(21):27. PubMed ID: 16796184
    [No Abstract]   [Full Text] [Related]  

  • 4. [Investigation today for practice tomorrow].
    Klein H
    Dtsch Med Wochenschr; 2013 May; 138(18):933. PubMed ID: 23613370
    [No Abstract]   [Full Text] [Related]  

  • 5. Should future health-care costs be discounted? The case of diabetes in Australia.
    Scuffham PA
    Intern Med J; 2006 Mar; 36(3):148-9. PubMed ID: 16503948
    [No Abstract]   [Full Text] [Related]  

  • 6. [Health economics analysis of diabetes is necessary. It facilitates decision-making and international comparison].
    Henriksson F; Agardh CD; Berne C; Bolinder J; Jönsson B
    Lakartidningen; 1999 Sep; 96(37):3915-6, 3919. PubMed ID: 10522101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costly type 2 diabetes mellitus. Does diabetes cost 20 billion per year?].
    Liebl A; Goertz A; Henkel B; Spannheimer A
    MMW Fortschr Med; 2000 Jun; 142(23):39-42. PubMed ID: 10900951
    [No Abstract]   [Full Text] [Related]  

  • 8. [A cost of illness study of diabetes mellitus].
    von Ferber L; Köster I; Hauner H
    Gesundheitswesen; 1997 Jan; 59(1):17-22. PubMed ID: 9138642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economics under scrutiny - experts discuss long acting insulin analogs].
    Pflege Z; 2011 Jan; 64(1):58. PubMed ID: 21305792
    [No Abstract]   [Full Text] [Related]  

  • 10. [How many diabetic patients in your practice? Important references for regress defense].
    MMW Fortschr Med; 2005 Oct; 147(40):48-9. PubMed ID: 16255517
    [No Abstract]   [Full Text] [Related]  

  • 11. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity and diabetes mellitus: increasing problems call for increasing efforts].
    Nauck M
    Dtsch Med Wochenschr; 2010 May; 135(18):901. PubMed ID: 20425673
    [No Abstract]   [Full Text] [Related]  

  • 13. [Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].
    Liebl A; Spannheimer A; Reitberger U; Görtz A
    Med Klin (Munich); 2002 Dec; 97(12):713-9. PubMed ID: 12491064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The 2005 BayRad Initiative. Cardiovascular prevention--more necessary than ever].
    Rothe HJ
    Krankenpfl J; 2005; 43(4-6):111. PubMed ID: 16171057
    [No Abstract]   [Full Text] [Related]  

  • 15. [How Germany manages it's diabetic patients].
    Einecke D
    MMW Fortschr Med; 1999 Oct; 141(42):4-5. PubMed ID: 10912093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Costs of type 2 diabetes in Germany. Results of the CODE-2 study].
    Liebl A; Neiss A; Spannheimer A; Reitberger U; Wagner T; Görtz A
    Dtsch Med Wochenschr; 2001 May; 126(20):585-9. PubMed ID: 11402924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comment on R. Diel, K. Ahrens, M. Talaulicar, B. Jaeschke. Additional food payments in diabetes mellitus in social law: what is required?].
    Becker W; Güse ML; Hilbert T
    Gesundheitswesen; 1996 Jan; 58(1):53; author reply 55-6. PubMed ID: 8851134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Insulin therapy in type 2 diabetes. Insured patients would be willing to pay for added benefits].
    MMW Fortschr Med; 2008 Dec; 150(49-50):56-7. PubMed ID: 19133372
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comprehensive diabetes therapy despite budget controls. Challenges for the general practice team].
    Bucklitsch M; Lichte T
    MMW Fortschr Med; 1999 Sep; 141(36):41. PubMed ID: 10904597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes disease management program. What is its purpose?].
    Stoschek J
    MMW Fortschr Med; 2006 May; 148(19):49, 51. PubMed ID: 16736710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.